Diamond Equity Research valuation A$0.48 per share, page-9

"Doesn't seem to be much point reading it"

Have you read the report ?
( unlikely )
Are you familiar with the IP progress and proving ( trials in progress )
( unlikely )
I guess your time is too valuable to take 15 minutes - to scan the content ( and more if you understand what is being said and would like to cross reference against the company announcements and various interviews along the way .
( unlikely )

Its like IMU are advertising how great their food is or other spurious claims
made by paid advertisements .

IMU by definition is involved in a lot of activities & getting a detailed over view
regardless of if the report is written by a totally arms lengths person or some one who gets paid for doing it .

How about you write your own report & put it up - just so we can all get a good unbiased view of what IMU are actually doing
( totally unlikely )

You might round it off with some comment on the potential implications of IMU's different IP platforms & the potential to change the global oncology treatment scenario .

Perhaps you could add some comment too relating to

a) The multiple reported side effects from the current SoC treatments experienced by cancer patients

b) The probability of extending life across various cancer types being treated with the current and accepted modes of treatments

c) You might also prepare some data on the current costs of many treatment regimes

We Look forward to your work and valuable contribution to the knowledge pool & regardless of the perceived quality & content it will be read

Thanks & have a great day